Clinical Trial Update: A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase I study of STA-5312 in subjects with advanced or metastatic solid tumors has completed enrollment. No efficacy or safety results are provided in this upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• STA-5312

Snippet

Sponsor: Synta Pharmaceuticals Corp. | Conditions: Advanced or Metastatic Solid Tumors | Phase 1 | Status: COMPLETED